EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Use of the Slow-Delivery Platform, VacSIM, Shapes the Host Immune Response to Increase Protection Against Influenza Infection

Anna L McCormick, Ted M Ross iD, Donald A Harn, Jarrod J Mousa iD

Viruses · 2025

DOI: 10.3390/v17091190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Anna L McCormick und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA. Hauptthemen laut MEDLINE: Influenza Vaccines, Orthomyxoviridae Infections, Hemagglutinin Glycoproteins, Influenza Virus. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Collaborative Influenza Vaccine Innovation Centers (CIVIC), NIH, Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza virus is a leading cause of global morbidity and mortality due to acute lower respiratory infection, even with the widespread use of multiple licensed influenza vaccines. However, antigenic drift during influenza replication can cause vaccine-induced antibodies to poorly neutralize influenza virus, thereby reducing vaccine effectiveness. To help overcome this problem, we leveraged a hydrogel platform with influenza hemagglutinin (HA) protein to induce prolonged antigen exposure. The hydrogel platform, Vaccine Self-Assembling Immune Matrix (VacSIM®), in combination with recombinant influenza H1 or H3 HA protein antigens, increased antigen-specific antibody titers in vaccinated mice, which led to decreased disease severity after H1N1 infection for H1 HA-vaccinated mice and decreased lung viral titers after H3N2 challenge for H3 HA-vaccinated mice. Sera collected from mice immunized with VacSIM and HA also showed broader HAI activity, increasing by 1–3 log against a panel of influenza viruses. These results were consistent with the use of cocktail immunization, containing both an H1 and H3 HA, where mice immunized with VacSIM had an increase in antigen-specific antibody titers and decreased disease severity and lung viral titers against H1N1 and H3N2 influenza challenges, respectively. Finally, it was determined that a single immunization with VacSIM and H1 HA could provide protection against lethal H1N1 challenge compared to a group without VacSIM. In summary, we demonstrate that use of the slow-release platform VacSIM can improve the host immune response to vaccination and increase protection against influenza infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesOrthomyxoviridae InfectionsHemagglutinin Glycoproteins, Influenza VirusAnimalsAntibodies, ViralMiceInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeFemaleMice, Inbred BALB CLungHumansInfluenza, HumanVaccinationHydrogels

Stichwörter der Autor:innen

COBRAantibodyhemagglutinininfluenzaslow-deliveryvaccine

Substanzen

Influenza VaccinesAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusHydrogels

Autor:innen und Institutionen

  • Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.
  • Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.
  • Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL 32304, USA.
  • Florida Research and Innovation Center, Cleveland Clinic Florida, 9801 SW Discovery Way, Port Saint Lucie, FL 34986, USA.
  • Department of Infection Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.

ORCID-Profile: Ted M Ross, Jarrod J Mousa

Förderung

  • NIAID NIH HHS
  • Collaborative Influenza Vaccine Innovation Centers (CIVIC)
  • NIH, Department of Health and Human Services

Zitieren

APA

McCormick, A. L., Ross, T. M., Harn, D. A., & Mousa, J. J. (2025). Use of the Slow-Delivery Platform, VacSIM, Shapes the Host Immune Response to Increase Protection Against Influenza Infection. Viruses. https://doi.org/10.3390/v17091190

Vancouver

McCormick AL, Ross TM, Harn DA, Mousa JJ. Use of the Slow-Delivery Platform, VacSIM, Shapes the Host Immune Response to Increase Protection Against Influenza Infection. Viruses. 2025. doi:10.3390/v17091190

BibTeX
@article{McCormick2025,
  author = {McCormick, Anna L and Ross, Ted M and Harn, Donald A and Mousa, Jarrod J},
  title = {Use of the Slow-Delivery Platform, VacSIM, Shapes the Host Immune Response to Increase Protection Against Influenza Infection},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17091190}
}
Kostenlos starten →